Published in PLoS Comput Biol on July 12, 2012
Data sharing policy design for consortia: challenges for sustainability. Genome Med (2014) 1.21
Data sharing in large research consortia: experiences and recommendations from ENGAGE. Eur J Hum Genet (2013) 1.14
Facilitating a culture of responsible and effective sharing of cancer genome data. Nat Med (2016) 1.13
The International Cancer Genome Consortium's evolving data-protection policies. Nat Biotechnol (2014) 0.96
Questioning the limits of genomic privacy. Am J Hum Genet (2012) 0.95
From tissues to genomes. G3 (Bethesda) (2013) 0.87
Epigenome data release: a participant-centered approach to privacy protection. Genome Biol (2015) 0.84
Living laboratory: whole-genome sequencing as a learning healthcare enterprise. Clin Genet (2014) 0.83
The translational potential of research on the ethical, legal, and social implications of genomics. Genet Med (2014) 0.82
Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma. World J Gastroenterol (2013) 0.81
Hypoxia-inducible factors enhance glutamate signaling in cancer cells. Oncotarget (2014) 0.80
"You want the right amount of oversight": interviews with data access committee members and experts on genomic data access. Genet Med (2016) 0.79
The ethics weathervane. BMC Med Ethics (2015) 0.78
Pseudonymization of patient identifiers for translational research. BMC Med Inform Decis Mak (2013) 0.77
Policy recommendations for addressing privacy challenges associated with cell-based research and interventions. BMC Med Ethics (2014) 0.77
Analysis of five years of controlled access and data sharing compliance at the International Cancer Genome Consortium. Nat Genet (2016) 0.77
Registered access: a 'Triple-A' approach. Eur J Hum Genet (2016) 0.77
Ethical considerations of research policy for personal genome analysis: the approach of the Genome Science Project in Japan. Life Sci Soc Policy (2014) 0.75
'Pop-Up' Governance: developing internal governance frameworks for consortia: the example of UK10K. Life Sci Soc Policy (2015) 0.75
TCGA2BED: extracting, extending, integrating, and querying The Cancer Genome Atlas. BMC Bioinformatics (2017) 0.75
Who should have access to genomic data and how should they be held accountable? Perspectives of Data Access Committee members and experts. Eur J Hum Genet (2016) 0.75
A decision tool to guide the ethics review of a challenging breed of emerging genomic projects. Eur J Hum Genet (2016) 0.75
Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations. Cancer Res (2016) 0.75
Resolving individuals contributing trace amounts of DNA to highly complex mixtures using high-density SNP genotyping microarrays. PLoS Genet (2008) 20.38
Prepublication data sharing. Nature (2009) 12.24
Genetics. Genomic research and human subject privacy. Science (2004) 6.56
Data sharing by scientists: practices and perceptions. PLoS One (2011) 6.48
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Sharing research data to improve public health. Lancet (2011) 4.81
Research ethics paperwork: what is the plot we seem to have lost? BMJ (2004) 4.05
Regulation--the real threat to clinical research. BMJ (2008) 3.95
Bayesian method to predict individual SNP genotypes from gene expression data. Nat Genet (2012) 2.50
Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform. Milbank Q (2011) 2.29
Ethical data release in genome-wide association studies in developing countries. PLoS Med (2009) 2.23
Share and share alike: deciding how to distribute the scientific and social benefits of genomic data. Nat Rev Genet (2007) 1.83
Genomic databases access agreements: legal validity and possible sanctions. Hum Genet (2011) 1.72
'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration. Public Health Genomics (2010) 1.57
To share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med (2011) 1.52
On sharing quantitative trait GWAS results in an era of multiple-omics data and the limits of genomic privacy. Am J Hum Genet (2012) 1.49
Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics (2011) 1.40
Developing and implementing an institute-wide data sharing policy. Genome Med (2011) 1.32
Genomics and privacy: implications of the new reality of closed data for the field. PLoS Comput Biol (2011) 1.29
Scientific publishing. Paper retracted following genome data breach. Science (2009) 0.92
A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39
International network of cancer genome projects. Nature (2010) 20.35
Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27
Prepublication data sharing. Nature (2009) 12.24
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet (2002) 8.89
A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet (2009) 8.30
Public access to genome-wide data: five views on balancing research with privacy and protection. PLoS Genet (2009) 2.80
Quality, quantity and harmony: the DataSHaPER approach to integrating data across bioclinical studies. Int J Epidemiol (2010) 2.44
Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat Genet (2007) 2.35
DataSHIELD: resolving a conflict in contemporary bioscience--performing a pooled analysis of individual-level data without sharing the data. Int J Epidemiol (2010) 2.23
Research priorities. ELSI 2.0 for genomics and society. Science (2012) 2.10
Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet (2007) 2.07
Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am J Hum Genet (2004) 2.04
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.93
A human rights approach to an international code of conduct for genomic and clinical data sharing. Hum Genet (2014) 1.90
Mutations in the gene encoding the Sigma 2 subunit of the adaptor protein 1 complex, AP1S2, cause X-linked mental retardation. Am J Hum Genet (2006) 1.85
Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet (2007) 1.73
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet A (2004) 1.72
Genomic databases access agreements: legal validity and possible sanctions. Hum Genet (2011) 1.72
Data sharing, year 1--access to data from industry-sponsored clinical trials. N Engl J Med (2014) 1.57
Genetic information and testing in insurance and employment: technical, social and ethical issues. Eur J Hum Genet (2003) 1.45
Is rigorous retrospective harmonization possible? Application of the DataSHaPER approach across 53 large studies. Int J Epidemiol (2011) 1.41
Legal approaches regarding health-care decisions involving minors: implications for next-generation sequencing. Eur J Hum Genet (2017) 1.39
Governing stem cell banks and registries: emerging issues. Stem Cell Res (2009) 1.37
Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.31
Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet (2010) 1.29
Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. Am J Hum Genet (2007) 1.26
'Regular science' is inherently political. EMBO Rep (2012) 1.23
End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine. Curr Pharmacogenomics Person Med (2012) 1.23
The expansion of newborn screening: is reproductive benefit an appropriate pursuit? Nat Rev Genet (2009) 1.21
Preconception care and genetic risk: ethical issues. J Community Genet (2011) 1.13
Mind the gap: policy approaches to embryonic stem cell and cloning research in 50 countries. Eur J Health Law (2006) 1.12
Disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med (2012) 1.10
Building a data sharing model for global genomic research. Genome Biol (2014) 1.09
Power to the people: a wiki-governance model for biobanks. Genome Biol (2012) 1.08
Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA). Curr Pharmacogenomics Person Med (2011) 1.04
Demystifying biobanks. Hastings Cent Rep (2013) 1.02
The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendations. J Law Med Ethics (2014) 1.01
Biobanks: simplifying consent. Nat Rev Genet (2004) 1.01
Factors influencing intrafamilial communication of hereditary breast and ovarian cancer genetic information. Eur J Hum Genet (2009) 0.99
Steering vaccinomics innovations with anticipatory governance and participatory foresight. OMICS (2011) 0.97
Questioning the limits of genomic privacy. Am J Hum Genet (2012) 0.95
Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. Hum Reprod (2006) 0.93
From banking to international governance: fostering innovation in stem cell research. Stem Cells Int (2011) 0.93
Pharmacogenomic data sample collection and storage: ethical issues and policy approaches. Pharmacogenomics (2006) 0.93
Locus-specific databases: from ethical principles to practice. Hum Mutat (2005) 0.92
Sustained interaction: the new normal for stem cell repositories? Regen Med (2011) 0.92
Crowd-funded micro-grants for genomics and "big data": an actionable idea connecting small (artisan) science, infrastructure science, and citizen philanthropy. OMICS (2013) 0.92
Personalized medicine and access to health care: potential for inequitable access? Eur J Hum Genet (2012) 0.92
Policy and data-intensive scientific discovery in the beginning of the 21st century. OMICS (2011) 0.91
Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting. Genet Med (2013) 0.91
Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals. Prenat Diagn (2002) 0.90
Funders must encourage scientists to share. Nature (2015) 0.88
Paediatric biobanks: what makes them so unique? J Paediatr Child Health (2011) 0.87
A code of ethics for ethicists: what would Pierre Bourdieu say? "Do not misuse social capital in the age of consortia ethics". Am J Bioeth (2015) 0.86
Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation. Curr Pharmacogenomics Person Med (2013) 0.84
Theranostics, the 21st century bioeconomy and 'one health'. Interview by Tikki Pang. Expert Rev Mol Diagn (2012) 0.84
The ethical framing of personalized medicine. Curr Opin Allergy Clin Immunol (2014) 0.83
Emerging issues in paediatric health research consent forms in Canada: working towards best practices. BMC Med Ethics (2013) 0.83
Translating biotechnology to knowledge-based innovation, peace, and development? Deploy a Science Peace Corps--an open letter to world leaders. OMICS (2014) 0.82
Genetic information and life insurance: a 'real' risk? Eur J Hum Genet (2003) 0.82
Legal and ethical approaches to stem cell and cloning research: a comparative analysis of policies in Latin America, Asia, and Africa. J Law Med Ethics (2004) 0.82
Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk. Eur J Hum Genet (2013) 0.82
Ethical dimensions of genetics in pediatric neurology: a look into the future. Semin Pediatr Neurol (2002) 0.81
Fostering public cord blood banking and research in Canada. Stem Cells Dev (2013) 0.81
Vaccines of the 21st century and vaccinomics: data-enabled science meets global health to spark collective action for vaccine innovation. OMICS (2011) 0.80
The gene involved in X-linked agammaglobulinaemia is a member of the Src family of protein-tyrosine kinases. 1993. J Immunol (2012) 0.80
Trade-secret model: legal limitations. Science (2011) 0.80
What are some of the ELSI challenges of international collaborations involving biobanks, global sample collection, and genomic data sharing and how should they be addressed? Biopreserv Biobank (2014) 0.79
Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health. Curr Pharmacogenomics Person Med (2011) 0.79
What are the most oppressing legal and ethical issues facing biorepositories and what are some strategies to address them? Biopreserv Biobank (2011) 0.78
Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value. Curr Pharmacogenomics Person Med (2010) 0.78
Personalized dentistry meets OMICS and "one health": from Cinderella of healthcare to mainstream? OMICS (2015) 0.78
Rogers v. Whitaker and informed consent in Australia: a fair dinkum duty of disclosure. Med Law Rev (1993) 0.78
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. Am J Hum Genet (2016) 0.77
Direct-to-consumer theranostics, 21st century collective innovation and entrepreneurship. Interview by Barbara Prainsack. Expert Rev Mol Diagn (2012) 0.77
The commercialization of genomic research in Canada. Healthc Policy (2010) 0.77
Emerging ethical issues regarding digital health data. On the World Medical Association Draft Declaration on Ethical Considerations Regarding Health Databases and Biobanks. Croat Med J (2016) 0.75
Reconfiguring Social Value in Health Research Through the Lens of Liminality. Bioethics (2017) 0.75
Are we asking the right ethics questions on drug shortages? Suggestions for a global and anticipatory ethics framework. Am J Bioeth (2012) 0.75
ACCE, pharmacogenomics, and stopping clinical trials: time to extend the CONSORT statement? Am J Bioeth (2011) 0.75
Monetary payments for the procurement of oocytes for stem cell research: In search of ethical and political consistency. Stem Cell Res (2007) 0.75
Legal aspects of genetic databases for international biomedical research: the example of the International Cancer Genome Consortium (ICGC). Rev Derecho Genoma Hum (2013) 0.75
Currents in contemporary bioethics. Open access as benefit sharing? The example of publicly funded large-scale genomic databases. J Law Med Ethics (2012) 0.75
International Charter of principles for sharing bio-specimens and data. Eur J Hum Genet (2016) 0.75
The use of fresh embryos in stem cell research: ethical and policy issues. Cell Stem Cell (2008) 0.75
Stability of Attitudes to the Ethical Issues Raised by the Return of Incidental Genomic Research Findings in Children: A Follow-Up Study. Public Health Genomics (2015) 0.75